UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
or

Orchard Therapeutics Plc ADR (ORTX)

Orchard Therapeutics Plc ADR (ORTX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
16.70 +0.05 (+0.30%) 01/23/24 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 16.70 unch (unch) -
News & Headlines for Tue, Jan 23rd, 2024
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CHS, SLGC, ORTX

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

ORTX : 16.70 (+0.30%)
SLGC : 2.10 (-4.55%)
CHS : 7.59 (-0.13%)
Stocks End Slightly Lower Ahead of Friday’s Monthly U.S. Payroll Report

What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Thursday closed down -0.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.03%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed...

MDLZ : 65.63 (-2.60%)
TAP : 58.19 (-0.87%)
ORTX : 16.70 (+0.30%)
CDAY : 69.52 (+0.10%)
JNJ : 154.47 (-0.59%)
RIVN : 12.09 (+2.46%)
ABNB : 121.19 (+2.46%)
LW : 52.33 (-0.21%)
$IUXX : 19,170.17 (+2.55%)
CLX : 137.83 (-0.92%)
ZNM25 : 111-070 (+0.51%)
KDP : 34.42 (-2.19%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SP, ORTX, SUM

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

ORTX : 16.70 (+0.30%)
SUM : 52.49 (+0.08%)
SP : 53.99 (+0.04%)
Why Orchard Therapeutics Stock Is Soaring Today

A buyout offer is fueling a rise in the company's shares today.

ORTX : 16.70 (+0.30%)
KYKOF : 14.7500 (unch)
Stocks Move Lower as Bond Yields Firm

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.75%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.41%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.25%....

ORTX : 16.70 (+0.30%)
GCM25 : 3,346.9 (+1.60%)
CDAY : 69.52 (+0.10%)
JNJ : 154.47 (-0.59%)
RIVN : 12.09 (+2.46%)
ABNB : 121.19 (+2.46%)
LW : 52.33 (-0.21%)
TSCO : 48.98 (-3.45%)
^USDJPY : 142.699 (-0.52%)
$IUXX : 19,170.17 (+2.55%)
CLX : 137.83 (-0.92%)
ZNM25 : 111-070 (+0.51%)
Markets Today: Stocks Slip as Bond Yields Climb on U.S. Labor Market Strength

Morning Markets December E-Mini S&P 500 futures (ESZ2 3) are down -0.39%, and the Dec Nasdaq 100 E-Mini futures (NQZ2 3) are down -0.34%. Stock index futures this morning are moderately lower. A smaller-than-expected...

ORTX : 16.70 (+0.30%)
CDAY : 69.52 (+0.10%)
SLB : 34.80 (+2.26%)
CAG : 24.83 (-1.55%)
RIVN : 12.09 (+2.46%)
MRO : 28.55 (-1.28%)
TSCO : 48.98 (-3.45%)
NQM25 : 19,266.50 (+2.46%)
CLX : 137.83 (-0.92%)
OXY : 40.26 (+1.08%)
HAL : 21.20 (+2.86%)
ESM25 : 5,499.75 (+1.81%)
Are Gene Therapy Stocks The Market's Next Big Winners?

Biotechs Sarepta and BioMarin are among companies advancing cutting-edge gene therapies, although those treatments can come with a $2 million or more price.

SLDB : 3.64 (+2.25%)
ORTX : 16.70 (+0.30%)
CRSP : 38.90 (+0.93%)
SRPT : 61.38 (+3.18%)
BLUE : 4.11 (+0.49%)
BMRN : 62.58 (+1.03%)
EDIT : 1.5850 (+1.60%)
NVS : 110.96 (+0.75%)
REGN : 593.95 (+1.04%)
BIIB : 119.59 (+1.20%)
NTLA : 8.18 (+1.11%)
Orchard Therapeutics Reports Second Quarter 2022 Financial Results and Reviews Recent Business Highlights

Additional Libmeldy® reimbursement discussions advancing across Europe with product sales totaling $3.1M in Q2 and $8.2M YTD OTL-200 U.S. BLA filing for...

ORTX : 16.70 (+0.30%)
Orchard Therapeutics Announces Reimbursement Agreement Making Libmeldy Available for All Eligible MLD Patients in Italy

BOSTON and LONDON, April 11, 2022 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced it has reached...

ORTX : 16.70 (+0.30%)
Orchard Therapeutics Extends Runway into 2024, Focusing HSC Gene Therapy Platform Exclusively on Severe Neurometabolic Diseases and Research Platform

Libmeldy European launch momentum building with multiple MLD patients treated and strong recognition of value proposition; U.S. BLA filing of OTL-200 on...

ORTX : 16.70 (+0.30%)

Barchart Exclusives

Can Grain and Oilseed Prices Higher?
While corn, soybean, and wheat prices are higher than their most recent lows, they remain significantly lower than the 2022 high. As the agricultural commodities that feed and increasingly fuel the world are at the beginning of the 2025 crop year, the weather and other issues will determine the path of least resistance of prices. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective